Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

The State of Texas awarded contract HHSTX-6-0000407471 to Merck Sharp & Dohme Corp effective June 23, 2026, for the provision of childhood vaccines. The contract pricing references the Centers for Disease Control and Prevention (CDC) Federal Contract for Vaccines and Biologicals (CDC Federal Contract Number: 75D30125D00195) and was executed under the authority of Texas Government Code Section 2155.144, which permits the acquisition of goods or services for the benefit of clients enrolled in agency-operated programs pursuant to Texas Government Code Section 771.

The vaccine products covered under this contract include diphtheria and tetanus toxoids absorbed, rubella virus vaccine, and tetanus vaccine, as identified by their respective UNSPSC commodity codes. The contract also encompasses additional pharmaceutical agents classified under the NIGP category for serums, toxoids, and vaccines. While specific contract amounts, annual values, and performance periods are not provided in the award documentation, the contract structure indicates that pricing and terms are aligned with the existing CDC Federal Contract mechanism, ensuring standardized pricing and delivery terms for the state's vaccine procurement needs.